Clinical Trial Update: Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating electroporation therapy with bleomycin for pancreatic cancer was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Bleomycin (bleomycin)

Snippet

Sponsor: Ichor Medical Systems Incorporated | Conditions: Pancreatic Cancer | Phase 1 | Status: WITHDRAWN